Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma

被引：0
|
作者：
Ganguly, Shuvadeep [1 ]
Gogia, Ajay [1 ]
机构：
[1] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi, India
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 08期
关键词：
D O I：
10.1001/jamaoncol.2022.2062
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1223 / 1224
页数：2
相关论文
共 50 条
  • [41] MRI of nasopharyngeal carcinoma metastatic to the cerebellopontine angle
    Gouliamos, AD
    Athanassopoulou, A
    Moulopoulou, L
    Kalovidouris, A
    Kotoulas, G
    Liaou, A
    Vlahos, L
    Papavassiliou, C
    NEURORADIOLOGY, 1996, 38 (04) : 375 - 377
  • [42] Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study
    Ciuleanu, E.
    Irimie, A.
    Ciuleanu, T. E.
    Popita, V.
    Todor, N.
    Ghilezan, N.
    JOURNAL OF BUON, 2008, 13 (01): : 37 - 42
  • [43] Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment. in patients with metastatic breast cancer
    Surmeli, Zeki Gokhan
    Varol, Umut
    Cakar, Burcu
    Degirmenci, Mustafa
    Arslan, Cagatay
    Piskin, Gonul Demir
    Zengel, Baha
    Karaca, Burcak
    Sanli, Ulus Ali
    Uslu, Ruchan
    ONCOLOGY LETTERS, 2015, 10 (04) : 2598 - 2602
  • [44] The comparison of maintenance treatment with capecitabine (CMT) and non-maintenance treatment with capecitabine (non-CMT) in patients with metastatic breast cancer
    Dong, Guolei
    Jia, Yan
    Wang, Xiaorui
    Li, Shufen
    Wang, Chen
    Shi, Yehui
    Tong, Zhongsheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 8283 - 8287
  • [45] Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer
    Sherman, Scott K.
    Lange, Joel J.
    Dahdaleh, Fadi S.
    Rajeev, Rahul
    Gamblin, T. Clark
    Polite, Blase N.
    Turaga, Kiran K.
    JAMA ONCOLOGY, 2019, 5 (02) : 236 - 242
  • [46] Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience (vol 12, pg 1387, 2020)
    Guo, Q.
    Chen, M.
    Xu, H.
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2365 - 2366
  • [47] Long-term disease control in a metastatic squamous cell carcinoma of the oral cavity treated with maintenance metronomic capecitabine
    Muratori, Leonardo
    La Salvia, Anna
    Gorzegno, Gabriella
    Sperone, Paola
    Scagliotti, Giorgio, V
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (01) : 240 - 243
  • [48] Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study
    Yang, Rui
    Li, Ruichen
    Niu, Xiaoshuang
    Zhao, Yang
    Yan, Li
    Tian, Shu
    Zhu, Yi
    Qiu, Jianjian
    Wang, Xiaoshen
    ORAL ONCOLOGY, 2024, 158
  • [49] Capecitabine therapy for refractory metastatic thyroid carcinoma: A case series
    Gilliam, Lisa K.
    Kohn, Aimee D.
    Lalani, Tasneem
    Swanson, Paul E.
    Vasko, Vasyl
    Patel, Aneeta
    Livingston, Robert B.
    Pickett, Cheryl A.
    THYROID, 2006, 16 (08) : 801 - 810
  • [50] Efficacy of capecitabine-based combination therapy and singleagent capecitabine maintenance therapy in patients with metastatic breast cancer
    Huimin Lv
    Min Yan
    Mengwei Zhang
    Limin Niu
    Huiai Zeng
    Shude Cui
    ChineseJournalofCancerResearch, 2014, 26 (06) : 692 - 697
12345